Articles

Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas

Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
George Washington University Cancer Center, Washington, DC 20052
Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Departments of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Departments of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612
Haematologica Early view Jun 24, 2021 https://doi.org/10.3324/haematol.2021.278743